Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03348150 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

Study acronym: PERISCOPEII
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 17, 2025 (before its estimated September 17, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment target: 182 to 102 Primary completion date: Oct 1, 2026 to Sep 17, 2025 · Trial status: Recruiting to Active, Not Recruiting · Completion date: Oct 1, 2029 to Oct 1, 2027 · 1 morev5 Show 4 more changesShow less
    • Primary completion date: Oct 1, 2026 to Sep 17, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Oct 1, 2029 to Oct 1, 2027
    • Site details revised
  2. Re-verified, no change to tracked fieldsv4
  3. Primary completion date: Oct 1, 2021 to Oct 1, 2026 Completion date: Oct 1, 2022 to Oct 1, 2029v3 Show 1 more changeShow less
    • Completion date: Oct 1, 2022 to Oct 1, 2029
  4. Enrollment target: 106 to 182 Primary completion date: Oct 1, 2020 to Oct 1, 2021 · Study description shortened, about 23 words · Site contact updated · 1 morev2 Show 4 more changesShow less
    • Primary completion date: Oct 1, 2020 to Oct 1, 2021
    • Study description shortened, about 23 words
    • Site contact updated
    • Collaborators revised (4)

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A randomized controlled two-armed phase III trial for gastric cancer patients with peritoneal dissemination. Randomization between gastrectomy + cytoreductive surgery + HIPEC (experimental arm) and palliative systemic chemotherapy (standard arm).
Trial Details
NCT Number NCT03348150
Lead Sponsor The Netherlands Cancer Institute
Collaborators: Erasmus Medical Center, UMC Utrecht, University Medical Center Groningen, Catharina Ziekenhuis Eindhoven
Conditions Stomach Neoplasm, Peritoneal Carcinomatosis
Enrollment 102 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov